End-stage heart failure refractory to medical therapy is a clinical challenge. Heart transplantation is considered the best strategy, but it remains burdened with substantial limitations due to the scanty availability of facilities with a transplant programme, donor shortage, and unpredictable waiting lists. Alternatively, assist devices may allow an improvement of the haemodynamic conditions, modifying the history of end-stage heart failure and introducing new management strategies. The goal of a minimally invasive short-term circulatory support device in the treatment of end-stage heart failure patients awaiting heart transplant is to restore the haemodynamic conditions and to improve end-organ dysfunction, with a low incidence of major adverse cardiac events. This report describes the first implantation in Italy of a new percutaneous circulatory support device, the Cancion cardiac recovery system, in a patient with severe end-stage heart failure listed for transplantation.

Mammana, C., Tespili, M., Costalunga, A., Jacovoni, A., Veritti, U., Lorini, F., et al. (2006). Treatment of refractory heart failure with a percutaneous circulatory support device. JOURNAL OF CARDIOVASCULAR MEDICINE, 7(6), 443-447 [10.2459/01.JCM.0000228698.37773.d2].

Treatment of refractory heart failure with a percutaneous circulatory support device

Lorini F;
2006

Abstract

End-stage heart failure refractory to medical therapy is a clinical challenge. Heart transplantation is considered the best strategy, but it remains burdened with substantial limitations due to the scanty availability of facilities with a transplant programme, donor shortage, and unpredictable waiting lists. Alternatively, assist devices may allow an improvement of the haemodynamic conditions, modifying the history of end-stage heart failure and introducing new management strategies. The goal of a minimally invasive short-term circulatory support device in the treatment of end-stage heart failure patients awaiting heart transplant is to restore the haemodynamic conditions and to improve end-organ dysfunction, with a low incidence of major adverse cardiac events. This report describes the first implantation in Italy of a new percutaneous circulatory support device, the Cancion cardiac recovery system, in a patient with severe end-stage heart failure listed for transplantation.
Articolo in rivista - Articolo scientifico
Circulatory-assist device; Heart failure
English
2006
7
6
443
447
none
Mammana, C., Tespili, M., Costalunga, A., Jacovoni, A., Veritti, U., Lorini, F., et al. (2006). Treatment of refractory heart failure with a percutaneous circulatory support device. JOURNAL OF CARDIOVASCULAR MEDICINE, 7(6), 443-447 [10.2459/01.JCM.0000228698.37773.d2].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/337397
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
Social impact